Idarucizumab Reverses Dabigatran in Elderly or Renally Impaired

Article Figures & Data

Figures

  • Figure 1.

    Effect of Idarucizumab on the Anticoagulation Effect of Dabigatran

    DE, dabigatran etexilate; dTT, diluted thrombin time; RI, renal impairment (CLcr: mild RI ≥ 60 to < 90 mL/min; moderate RI ≥ 30 to < 60 mL/min); TT, thrombin time.

    Reproduced with permission from J Stangier, PhD.